The report highlights the company's progress in environmental, social and governance (ESG) initiatives in 2020. The report covers 16+ indicators in accordance with the BioPharma Alliance, as well as GRI, NBIM and SASB. The company achieved significant milestones in its ESG journey, including meeting or exceeding all 19 targets in support of its five Sustainability 2020 Goals. The company also launched a new 2030 and 2040 Environmental Goals, including 100% energy purchased from renewable sources, net neutral GHG emissions, and zero waste to landfill.
Issuing Company Bristol-Myers Squibb Company
Report Type Sustainability Report
Report Language EN
Report Filesize 7.09 MB
No. of Pages 82 pages
Reporting period2020
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards GRI; SASB; NBIM; others
Materiality Assessmenttrue